Tobacco addiction and the dysregulation of brain stress systems

被引:117
作者
Bruijnzeel, Adrie W. [1 ]
机构
[1] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA
关键词
Tobacco; Nicotine; Addiction; Dependence; Depression; Anxiety; CRF; NPY; Hypocretin; Norepinephrine; CORTICOTROPIN-RELEASING-FACTOR; PRECIPITATED NICOTINE WITHDRAWAL; PITUITARY-ADRENAL AXIS; NEUROPEPTIDE-Y NPY; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; OLFACTORY BULBECTOMIZED RAT; BUNGAROTOXIN BINDING-SITES; RECEPTOR PARTIAL AGONIST; SOCIAL-INTERACTION TEST; CENTRAL-NERVOUS-SYSTEM;
D O I
10.1016/j.neubiorev.2012.02.015
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Tobacco is a highly addictive drug and is one of the most widely abused drugs in the world. The first part of this review explores the role of stressors and stress-associated psychiatric disorders in the initiation of smoking, the maintenance of smoking, and relapse after a period of abstinence. The reviewed studies indicate that stressors facilitate the initiation of smoking, decrease the motivation to quit, and increase the risk for relapse. Furthermore, people with depression or an anxiety disorder are more likely to smoke than people without these disorders. The second part of this review describes animal studies that investigated the role of brain stress systems in nicotine addiction. These studies indicate that corticotropin-releasing factor, Neuropeptide Y, the hypocretins, and norepinephrine play a pivotal role in nicotine addiction. In conclusion, the reviewed studies indicate that smoking briefly decreases subjective stress levels but also leads to a further dysregulation of brain stress systems. Drugs that decrease the activity of brain stress systems may diminish nicotine withdrawal and improve smoking cessation rates. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1418 / 1441
页数:24
相关论文
共 389 条
  • [51] Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress
    Cecchi, M
    Khoshbouei, H
    Javors, M
    Morilak, DA
    [J]. NEUROSCIENCE, 2002, 112 (01) : 13 - 21
  • [52] Corticotrophin-releasing factor receptors: From molecular biology to drug design
    Chalmers, DT
    Lovenberg, TW
    Grigoriadis, DE
    Behan, DP
    DeSouza, EB
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (04) : 166 - 172
  • [53] Neuroanatomical circuits modulating fear and anxiety behaviors
    Charney, DS
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2003, 108 : 38 - 50
  • [54] NORADRENERGIC NEURONAL DYSREGULATION IN PANIC DISORDER - THE EFFECTS OF INTRAVENOUS YOHIMBINE AND CLONIDINE IN PANIC DISORDER PATIENTS
    CHARNEY, DS
    WOODS, SW
    KRYSTAL, JH
    NAGY, LM
    HENINGER, GR
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1992, 86 (04) : 273 - 282
  • [55] CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294
  • [56] CHARNEY DS, 1986, ARCH GEN PSYCHIAT, V43, P1042
  • [57] CHARNEY DS, 1981, ARCH GEN PSYCHIAT, V38, P1334
  • [58] Narcolepsy in orexin knockout mice:: Molecular genetics of sleep regulation
    Chemelli, RM
    Willie, JT
    Sinton, CM
    Elmquist, JK
    Scammell, T
    Lee, C
    Richardson, JA
    Williams, SC
    Xiong, YM
    Kisanuki, Y
    Fitch, TE
    Nakazato, M
    Hammer, RE
    Saper, CB
    Yanagisawa, M
    [J]. CELL, 1999, 98 (04) : 437 - 451
  • [59] A soluble mouse brain splice variant of type 2α corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity
    Chen, AM
    Perrin, MH
    DiGruccio, MR
    Vaughan, JM
    Brar, BK
    Arias, CM
    Lewis, KA
    Rivier, JE
    Sawchenko, PE
    Valet, WW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (07) : 2620 - 2625
  • [60] Smoking duration, intensity, and risk of Parkinson disease
    Chen, H.
    Huang, X.
    Guo, X.
    Mailman, R. B.
    Park, Y.
    Kamel, F.
    Umbach, D. M.
    Xu, Q.
    Hollenbeck, A.
    Schatzkin, A.
    Blair, A.
    [J]. NEUROLOGY, 2010, 74 (11) : 878 - 884